transcription factor inhibitor program (Cullgen)

N/A

Report date: 2025/01/26 17:41:18
NME

Base Information

Drug Nametranscription factor inhibitor program (Cullgen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factors inhibitors
TargetsTranscription factors
Therapy Area/IndicationsTriple Negative Breast NeoplasmsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCullgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesCullgen Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A